It would be good to know what "partial response" mean't and at what dosage (high/low). Will the partial response patient go on the receive a higher dosage?
Big plus.....no patience withdrawn from study once they commenced. This is a big big positive IMO.
Give this till next week to circle the news wire.
Good material for investor conference. I hope those who attend have good to questions and get more detail.
Ann: Kazia releases preliminary Cantrixil Phase I data, page-6
Add to My Watchlist
What is My Watchlist?